We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$3.01B
AUM Growth
-$77.5M
Cap. Flow
-$45.6M
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.99%
Holding
119
New
6
Increased
40
Reduced
57
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.4M
2
TDY icon
Teledyne Technologies
TDY
+$17.1M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$14.5M
4
IQV icon
IQVIA
IQV
+$13.6M
5
R icon
Ryder
R
+$12M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$25.9M
2
NOW icon
ServiceNow
NOW
+$22.6M
3
BSX icon
Boston Scientific
BSX
+$12.1M
4
MU icon
Micron Technology
MU
+$11.7M
5
WDC icon
Western Digital
WDC
+$9.36M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Financials 13.03%
3 Communication Services 10.89%
4 Industrials 10.55%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CME icon
26
CME Group
CME
$91.9B
$33M 1.1%
111,765
+7,560
+7% +$2.25M
GEV icon
27
GE Vernova
GEV
$275B
$32.9M 1.09%
37,661
-1,138
-3% -$888K
EVR icon
28
Evercore
EVR
$13B
$32.2M 1.07%
107,968
-2,423
-2% -$793K
MCK icon
29
McKesson
MCK
$96.5B
$31M 1.03%
35,798
-135
-0.4% -$120K
DGX icon
30
Quest Diagnostics
DGX
$25.2B
$30.7M 1.02%
156,832
+2,978
+2% +$579K
WFC icon
31
Wells Fargo
WFC
$261B
$30.7M 1.02%
386,044
-8,118
-2% -$697K
NDAQ icon
32
Nasdaq
NDAQ
$51.1B
$30.6M 1.02%
361,027
-14,632
-4% -$1.31M
MA icon
33
Mastercard
MA
$469B
$30.6M 1.02%
61,159
-278
-0.5% -$146K
APP icon
34
Applovin
APP
$134B
$30M 1%
75,433
-11,337
-13% -$5.48M
ASND icon
35
Ascendis Pharma A/S
ASND
$16.6B
$30M 1%
130,992
+11,897
+10% +$2.67M
GS icon
36
Goldman Sachs
GS
$317B
$29.8M 0.99%
35,229
+1,021
+3% +$911K
MRK icon
37
Merck
MRK
$322B
$29.6M 0.98%
+246,022
New +$28.4M
CAT icon
38
Caterpillar
CAT
$412B
$27.5M 0.91%
38,829
+1,924
+5% +$1.33M
AZO icon
39
AutoZone
AZO
$47.7B
$27.2M 0.9%
8,047
-83
-1% -$298K
KO icon
40
Coca-Cola
KO
$349B
$26.6M 0.88%
349,389
+8,376
+2% +$633K
TMUS icon
41
T-Mobile US
TMUS
$184B
$26.4M 0.88%
125,891
+3,839
+3% +$789K
MMM icon
42
3M
MMM
$87.5B
$26.4M 0.88%
181,596
-614
-0.3% -$97.8K
EQT icon
43
EQT Corp
EQT
$33.4B
$26.4M 0.88%
414,257
+3,618
+0.9% +$212K
WEC icon
44
WEC Energy
WEC
$37.4B
$26.3M 0.87%
227,286
+693
+0.3% +$77.9K
CSCO icon
45
Cisco
CSCO
$444B
$26.1M 0.87%
336,705
+1,477
+0.4% +$116K
QXO
46
QXO Inc
QXO
$14.4B
$26M 0.86%
1,336,330
+37,480
+3% +$858K
TKO icon
47
TKO Group
TKO
$13.5B
$25.9M 0.86%
128,585
+1,593
+1% +$326K
COP icon
48
ConocoPhillips
COP
$146B
$25.1M 0.83%
190,268
+18,203
+11% +$2.02M
BAC icon
49
Bank of America
BAC
$430B
$25M 0.83%
512,456
+984
+0.2% +$50.8K
SN icon
50
SharkNinja
SN
$20.6B
$24.3M 0.81%
229,560
+18,090
+9% +$2.12M
1
2
3 4 5

Similar funds

CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Braun Stacey Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Braun Stacey Associates held 119 positions worth $3.01B, down 2.5% from $3.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Braun Stacey Associates's Q1 2026 filing shows 6 new, 40 increased, 57 reduced and 7 closed positions. Its largest new stake was Merck: 246,022 shares worth $29.6M. The largest sale was Neurocrine Biosciences, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q1 2026 buy was Merck: 246,022 shares worth $29.6M.
  • Braun Stacey Associates added most to Ascendis Pharma A/S in Q1 2026, an estimated $2.67M increase.
  • Braun Stacey Associates's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $12.1M.
  • Braun Stacey Associates fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $25.9M.
  • Braun Stacey Associates's ten largest holdings make up 33% of its $3.01B portfolio in Q1 2026.
  • Braun Stacey Associates opened 6 new positions and closed 7 in Q1 2026.
  • Braun Stacey Associates's portfolio value fell 2.5% quarter-over-quarter to $3.01B.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.